✦ LIBER ✦

Rivaroxaban, dabigatran and enoxaparin for thromboprophylaxis after total hip arthroplasty: Efficacy, safety, analysis of costs in elderly patients

✍ Scribed by Bashlakova, E.; Vorobiev, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban versus enoxaparin for thromb

✍ Yong Bing Cao; Jun Dong Zhang; Hui Shen; Yuan Ying Jiang 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 659 KB

PCV11 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Pereira, R; Duran, A; Lindner, L; Toro, W; Arango, CH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

A Cost-Effectiveness Model Comparing Riv

✍ McCullagh, Laura; Tilson, Lesley; Walsh, Cathal; Barry, Michael 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 315 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Dabigatran, Rivaroxaban and Apixaban ver

✍ José A. Nieto; Noelia Garrido Espada; Ricardo Guijarro Merino; Timoteo Cámara Go 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 568 KB

A multi-perspective cost-effectiveness a

✍ Sonja Zindel, Stephanie Stock, Dirk Müller, Björn Stollenwerk 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 934 KB